Back to search
5-methoxy-dimethyltryptamine (5-MeO-DMT)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which 5-methoxy-dimethyltryptamine (5-MeO-DMT) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which 5-methoxy-dimethyltryptamine (5-MeO-DMT) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This is an observational study which does NOT directly administer a psychedelic substance but rather recruits participants who are already participating in anot…
Participation in this study lasts approximately two weeks and includes three on-site study visits: a screening visit (approximately 2 hours), a study drug admin…
The primary objectives of this trial are to determine the pharmacokinetic (PK) profile and the safety and tolerability of GH001 delivered via a proprietary aero…
The primary objectives of this trial are to determine the pharmacokinetic (PK) profile and the safety and tolerability of GH001 delivered via a proprietary aero…
The aim of this randomized, double-blind, placebo-controlled, phase 2b clinical trial is to investigate the safety and efficacy of GH001 (containing mebufotenin…